@article {1550,
	title = {Prophylaxis for human immunodeficiency virus-related Pneumocystis carinii pneumonia: using simulation modeling to inform clinical guidelines.},
	journal = {Archives of internal medicine},
	volume = {162},
	year = {2002},
	month = {2002 Apr 22},
	pages = {921-8},
	abstract = {Human immunodeficiency virus (HIV)-infected patients receiving highly active antiretroviral therapy (HAART) have experienced a dramatic decrease in Pneumocystis carinii pneumonia (PCP), necessitating reassessment of clinical guidelines for prophylaxis.},
	keywords = {AIDS-Related Opportunistic Infections, Anti-Infective Agents, Antiprotozoal Agents, Atovaquone, CD4 Lymphocyte Count, Cost-Benefit Analysis, Dapsone, Drug Costs, Humans, Life Expectancy, Models, Theoretical, Naphthoquinones, Pentamidine, Pneumonia, Pneumocystis, Practice Guidelines as Topic, Quality-Adjusted Life Years},
	issn = {0003-9926},
	doi = {10.1111/j.1524-4733.2010.00763.x},
	author = {Goldie, Sue J and Kaplan, Jonathan E and Losina, Elena and Weinstein, Milton C and Paltiel, A David and Seage, George R and Craven, Donald E and Kimmel, April D and Zhang, Hong and Cohen, Calvin J and Freedberg, Kenneth A}
}
